Financial results - ORGANON BIOTEC SRL

Financial Summary - Organon Biotec Srl
Unique identification code: 31676771
Registration number: J22/921/2013
Nace: 4646
Sales - Ron
543.056
Net Profit - Ron
47.934
Employees
3
Open Account
Company Organon Biotec Srl with Fiscal Code 31676771 recorded a turnover of 2024 of 543.056, with a net profit of 47.934 and having an average number of employees of 3. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Organon Biotec Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 64.500 61.207 55.862 39.354 68.968 799.615 545.696 835.677 695.010 543.056
Total Income - EUR 64.500 61.230 55.945 39.354 71.662 802.554 545.739 841.108 714.196 548.967
Total Expenses - EUR 64.358 59.640 51.245 36.422 61.605 653.679 444.946 598.569 553.344 495.389
Gross Profit/Loss - EUR 142 1.590 4.700 2.932 10.057 148.875 100.793 242.539 160.852 53.578
Net Profit/Loss - EUR 119 202 3.024 2.268 9.367 141.346 96.934 236.831 154.804 47.934
Employees 1 1 0 1 1 1 1 2 2 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -21.4%, from 695.010 euro in the year 2023, to 543.056 euro in 2024. The Net Profit decreased by -106.004 euro, from 154.804 euro in 2023, to 47.934 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Organon Biotec Srl

Rating financiar

Financial Rating -
ORGANON BIOTEC SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Organon Biotec Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Organon Biotec Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Organon Biotec Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Organon Biotec Srl - CUI 31676771

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 5.536 3.328 3.017 3.138 3.915 2.370 806 41.188 42.605 56.016
Current Assets 10.667 21.103 24.563 15.116 31.038 219.884 204.072 215.682 412.788 284.168
Inventories 0 1.037 0 0 0 52.942 17.185 16.198 31.526 21.403
Receivables 5.317 14.636 11.346 7.462 7.886 117.291 117.736 161.188 214.013 172.478
Cash 5.350 5.430 13.217 7.655 23.152 49.651 69.151 38.296 167.249 90.287
Shareholders Funds 3.772 3.945 6.902 9.043 13.599 116.387 159.523 191.936 280.235 162.717
Social Capital 45 53 53 52 51 50 2.030 2.036 2.022 2.010
Debts 12.431 20.486 20.678 9.212 21.354 105.868 45.356 64.934 175.158 181.280
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 284.168 euro in 2024 which includes Inventories of 21.403 euro, Receivables of 172.478 euro and cash availability of 90.287 euro.
The company's Equity was valued at 162.717 euro, while total Liabilities amounted to 181.280 euro. Equity decreased by -115.952 euro, from 280.235 euro in 2023, to 162.717 in 2024.

Risk Reports Prices

Reviews - Organon Biotec Srl

Comments - Organon Biotec Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.